London-based Unravel Health raised €2.96 million led by Conduit EIS Impact Fund and Wrightwood.
Why it matters: The round shows how a saliva-based hormone reader is being funded toward early-access devices in 2027, with the same sensing technology already tested on other markers.
Silvia Bio, a University of Sheffield spinout, raised £3 million in seed funding led by Northern Gritstone.
Denver-based Intero Biosystems sells GastroScreen, a human intestinal organoid model about one millimeter across.
Stride, the preventive health membership founded by Olympic medalist Andrew Steele.
Why it matters: Stride's seed round shows how consumer preventive health is being built around lab diagnostics and an AI copilot, with retention as the open question.
Polyphron raised $20M in seed funding led by Quiet Capital, with Haystack, Gradient and Compound participating. The New York company grows donor-defined human tissue in an automated lab.
Why it matters: The interview details how Polyphron pairs lab-grown human tissue with longitudinal data to train predictive models, a concrete look at the tissue-as-verification layer for drug testing.
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing
